Christopher Hill - Core Laboratories Chief Financial Officer, Senior Vice President

CLB
 Stock
  

USD 16.59  0.57  3.32%   

  President
Mr. Christopher S. Hill has served as Chief Financial Officer of Core Laboratories N.V. since June 25, 2018. He served as Chief Financial Officer, Chief Accounting Officer of the Company between May 18, 2018 and June 25, 2018. He was Senior Vice President, Chief Accounting Officer of the Company between April 30, 2015 and May 18, 2018. Since joining the Company in October 2006, Mr. Hill has held various positions including Corporationrationrate Controller Financial Reporting, Corporationrationrate Group Controller and Investor Relations. Prior to joining the Company, he worked at Halliburton from August 2000 to October 2006 as Controller Energy Chemicals of the KBR Division and Corporationrationrate Director of Training and Accounting Research. Mr. Hill worked at Ernst Young from January 1993 until August 2000, where he held the position of Manager his last three years there
Age: 51  President Since 2018  MBA    
31 20 420 3191  https://www.corelab.com
Hill holds a BBA in Accounting from Texas A&M University received in December 1992. He received an Executive MBA degree from Rice University in May 2018.

Christopher Hill Latest Insider Activity

Tracking and analyzing the buying and selling activities of Christopher Hill against Core Laboratories stock is an integral part of due diligence when investing in Core Laboratories. Christopher Hill insider activity provides valuable insight into whether Core Laboratories is net buyers or sellers over its current business cycle. Note, Core Laboratories insiders must abide by specific rules, including filing SEC forms every time they buy or sell Core Laboratories'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Core Laboratories Management Efficiency

Core Laboratories has Return on Asset of 3.53 % which means that on every $100 spent on asset, it made $3.53 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.55 %, implying that it generated $5.55 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Average Assets is expected to grow to 0.0349. The current year Return on Average Equity is expected to grow to 0.14. Core Laboratories Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 189.06 Million. The current year Assets Non Current is expected to grow to about 433 M, whereas Total Assets are forecasted to decline to about 571.3 M.
The company has 244.22 M in debt with debt to equity (D/E) ratio of 1.41, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.04, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Core Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Core Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core Laboratories to invest in growth at high rates of return. When we think about Core Laboratories' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

PRESIDENT Since

Bradford SmithMicrosoft Corp
2015
Douglas MuzykaDupont Denemours
2016
Richard McPhailHome Depot
2019
Marc GordonAmerican Express
2012
Stacy FoxDupont Denemours
2017
Matthew SmithIntel Corp
2018
Rolando SantosBaker Hughes A
2015
Rachel BrandWalmart
2018
Susan SobbottAmerican Express
2015
George DavisIntel Corp
2019
Margaret JohnsonMicrosoft Corp
2014
Leslie CulbertsonIntel Corp
2018
Todd MorgenfeldHP Inc
2013
Paul VaccaroIntel Corp
2016
Keith LorizioMicrosoft Corp
2016
JeanPhilippe CourtoisMicrosoft Corp
2016
Alex ChoHP Inc
2018
Susan ChambersWalmart
2006
Enrique LoresHP Inc
2019
Matthew TrerotolaDupont Denemours
2014
Steven RodgersIntel Corp
2017
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories operates under Oil Gas Equipment Services classification in the United States and is traded on New York Stock Exchange. It employs 3600 people. Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in Van Heuven Goedhartlaan 7 B and employs 3,600 people. Core Laboratories is listed under Petroleum and Natural category by Fama And French industry classification.

Core Laboratories Leadership Team

Elected by the shareholders, the Core Laboratories' board of directors comprises two types of representatives: Core Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core Laboratories. The board's role is to monitor Core Laboratories' management team and ensure that shareholders' interests are well served. Core Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Tahera Khan, Vice President Human Resources
Gwendolyn Schreffler, Senior Vice President, Corporate Development and Investor Relations
Lawrence Bruno, Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
Monique Eeuwijk, Non-Executive Independent Member of the Supervisory Board
D Ogren, Member of the Supervisory Board
Michael Flecker, Vice President Production Enhancement
Christopher Hill, Chief Financial Officer, Senior Vice President
Alastair Crombie, Vice President Reservoir Description
Mark Elvig, Senior Vice President, Secretary, and General Counsel
Harvey Klingensmith, Non-Executive Independent Member of the Supervisory Board
Michael Straughen, Non-Executive Independent Member of the Supervisory Board
John Ogren, Member of the Supervisory Board
Charles Dunlap, Independent Member of the Board of Supervisory Directors
Monty Davis, COO and Sr. VP
David Hume, Vice President Reservoir Description
J Dumas, Vice President Business Development
Martha Carnes, Presiding Non-Executive Lead Independent Member of the Supervisory Board
Richard Bergmark, CFO, Executive VP and Supervisory Director
Kevin Daniels, Vice President, Chief Accounting Officer
James Gresham, Senior Vice President Business Development
David Demshur, Independent Chairman of the Board of Supervisory Directors and Chief Executive Officer
Kwaku Temeng, Non-Executive Independent Member of the Supervisory Board
Michael Kearney, Independent Supervisory Director
Peter Boks, Vice President Reservoir Description
Gregory Barnett, Non-Executive Independent Member of the Supervisory Board
Chris Hill, Chief Accounting Officer and VP
Margaret Kempen, Independent Member of the Board of Supervisory Directors
Lucia Geuns, Independent Member of the Board of Supervisory Directors
Jeffrey West, Vice President Production Enhancement
Mark Tattoli, Senior Vice President General Counsel, Secretary
Dumas, Vice President Business Development
Gwendolyn Gresham, Senior Vice President Corporate Development and Investor Relations
Jan Sodderland, Independent Member of the Board of Supervisory Directors

Core Laboratories Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Core Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Core Laboratories Investors Sentiment

The influence of Core Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Core Laboratories. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Core Laboratories' public news can be used to forecast risks associated with investment in Core Laboratories. The trend in average sentiment can be used to explain how an investor holding Core Laboratories can time the market purely based on public headlines and social activities around Core Laboratories NV. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Core Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Core Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Core Laboratories' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Core Laboratories.

Core Laboratories Implied Volatility

    
  6.02  
Core Laboratories' implied volatility exposes the market's sentiment of Core Laboratories NV stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Core Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Core Laboratories stock will not fluctuate a lot when Core Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Laboratories

0.78ENSVEnservco Corpporation Earnings Call  TodayPairCorr
0.98HALHalliburton Downward RallyPairCorr

Moving against Core Laboratories

0.68RADRite Aid Corp Normal TradingPairCorr
0.52SBUXStarbucks Corp Fiscal Year End 27th of October 2022 PairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Core Laboratories information on this page should be used as a complementary analysis to other Core Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Core Laboratories Stock analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.12
Market Capitalization
794.9 M
Quarterly Revenue Growth YOY
0.018
Return On Assets
0.0353
Return On Equity
0.0555
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.